Clinical Trials Logo

Clinical Trial Summary

Periodontitis is a polymicrobial, inflammatory condition affecting tooth-supporting tissues. It is characterized by a progressive loss of epithelial attachment and resorption of alveolar bone, which can lead to tooth loss. Epithelial-mesenchymal transition (EMT) has been proposed as a reversible process that shifts the cell phenotype from epithelial to mesenchymal-like and may be involved in the process of periodontal inflammation either completely or partially. Long non-coding RNAs (lncRNAs) are a large class of regulatory transcripts longer than 200 nucleotides lacking evident protein-coding potential. Studies have shown that lncRNA dysregulation plays key roles in human diseases, including cancer, by modulating the epithelial-mesenchymal transition (EMT). The involvement of lncRNAs markers in the pathogenesis of periodontal disease induced EMT has not been studied thoroughly and have created a gap in the knowledge.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05995067
Study type Observational
Source University of Baghdad
Contact
Status Active, not recruiting
Phase
Start date February 14, 2022
Completion date January 30, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03509779 - Pronostic and Predictive Value of EMT in Localized Lung Cancer